{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-028457","form_type":"8-K","ticker":"GTBP","cik":"0000109657","company_name":"GT Biopharma, Inc.","filed_at":"2026-06-12T20:30:27+00:00","discovered_at":"2026-06-12T20:32:00.328483+00:00","generated_at":"2026-06-12T20:49:36.488117+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"GT Biopharma reduces stockholder meeting quorum from majority to one-third","bullets":["Board approved amendment to bylaws effective June 8, 2026.","Quorum lowered from majority to not less than one-third of outstanding voting shares.","Change aims to improve meeting attendance amid broker non-voting trends.","Company is fully remote as of July 1, 2024; no principal executive office."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-028457","json":"https://secwatch.observer/filing/0001493152-26-028457.json","markdown":"https://secwatch.observer/filing/0001493152-26-028457.md","text":"https://secwatch.observer/filing/0001493152-26-028457.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315226028457/0001493152-26-028457-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315226028457/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:49:36.488117+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b397cbd05d0f8a1241c7aac0c3ba029e197d76eb","claim":"GT Biopharma, Inc.: Reduced quorum requirement for stockholder meetings from a majority to not less than one-third of outstanding shares entitled to vote (effective 2026-06-08).","evidence_excerpt":"On June 8, 2026, the Board of Directors (the “Board”) of GT Biopharma, Inc., a Delaware corporation (the “Company”) approved an amendment (the “Amendment”) to the Company’s Amended and Restated Bylaws, effective June 8, 2026, to reduce the number of shares that are required to be present in person or by proxy at a meeting of the Company’s stockholders (a “Meeting”) for purposes of establishing a quorum.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/109657/000149315226028457/0001493152-26-028457-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2026-06-08"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}